Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer

ConclusionsThe RFS rate was lower in NMIBC patients who received GA during TURBT than in those who received SA. Volatile anesthesia may increase tumor recurrence, particularly in high-risk NMIBC patients, which may be due to the inhibition of the immune response system during surgery.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research

Related Links:

CONCLUSIONS: Older age was not associated with an increased risk of major complications in patients who undergo radical cystectomy because of MIBC. Therefore, older age alone should not be a contraindication to this operation.PMID:34950268 | PMC:PMC8669987 | DOI:10.5114/wiitm.2021.103918
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Authors: Source Type: research
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease wh...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Urol Oncol. 2020 Oct 23:S1078-1439(20)30477-4. doi: 10.1016/j.urolonc.2020.10.004. Online ahead of print.ABSTRACTNon-muscle-invasive bladder cancer is one of the most common malignancies. Patients with intermediate-risk or high-risk disease can be treated with intravesical Bacillus Calmette-Guerin, a vaccine against tuberculosis. However, many of these patients will experience tumor recurrence, despite appropriate treatment. 1 The standard of care in these patients is radical cystectomy (RC) with urinary diversion. 2 Patients diagnosed with muscle-invasive bladder cancer (MIBC) have traditionally faced 2 main treatment opt...
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research
More News: Anesthesia | Anesthesiology | Bladder Cancer | Cancer | Cancer & Oncology